Xian Lu

Local Ablative Therapy of Oligoprogressive Disease Prolongs Disease Control by Tyrosine Kinase Inhibitors in Oncogene-Addicted Non–Small-Cell Lung Cancer

Andrew Weickhardt, Benjamin Scheier, Joseph Burke et al. · Journal of Thoracic Oncology · 2012 · 663 citations · Full text

Local Ablative Therapy, Oncology, Novel Therapy +8

Oncogene status predicts patterns of metastatic spread in treatment‐naive nonsmall cell lung cancer

Robert C. Doebele, Xian Lu, Christopher Sumey et al. · Cancer · 2012 · 278 citations · Full text

Anaplastic Lymphoma Kinase Gene Rearrangements in Non-small Cell Lung Cancer are Associated with Prolonged Progression-Free Survival on Pemetrexed

D. Ross Camidge, Scott A. Kono, Xian Lu et al. · Journal of Thoracic Oncology · 2011 · 237 citations · Full text

Medicine, Pathology, Bronchial Neoplasm +5

Identifying the Appropriate FISH Criteria for Defining MET Copy Number–Driven Lung Adenocarcinoma through Oncogene Overlap Analysis

Sinéad Noonan, Lynne D. Berry, Xian Lu et al. · Journal of Thoracic Oncology · 2016 · 169 citations · Full text

Oncogenic Agent, Medicine, Appropriate Fish Criteria +9

PD-L1 Expression by Two Complementary Diagnostic Assays and mRNA In Situ Hybridization in Small Cell Lung Cancer

Hui Yu, Cory Batenchuk, A. Badzio et al. · Journal of Thoracic Oncology · 2016 · 134 citations · Full text

Oncology, Pd-l1 Expression, Medicine +10